INCB054329

· Incyte Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INCB054329, covering 2019-06-14 to 2019-06-14. Get the full timeline:

Most recent: Clinical Trial Update: An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies [Phase 1, Phase 2]